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Abstract
Background
Late-life depression is most often treated in primary care, and it usually coincides with
chronic somatic diseases. Given that antidepressants contribute to polypharmacy in these
patients, and potentially to interactions with other drugs, non-pharmacological treatments
are essential. In this systematic review and meta-analysis, we aimed to present an overview
of the non-pharmacological treatments available in primary care for late-life depression.
Method
The databases of PubMed, PsychINFO, and the Cochrane Central Register of Controlled
Trials were systematically searched in January 2017 with combinations of MeSH-terms and
free text words for “general practice,” “older adults,” “depression,” and “non-pharmacological
treatment”. All studies with empirical data concerning adults aged 60 years or older were
included, and the results were stratified by primary care, and community setting. We narra-
tively reviewed the results and performed a meta-analysis on cognitive behavioral therapy in
the primary care setting.
Results
We included 11 studies conducted in primary care, which covered the following five treat-
ment modalities: cognitive behavioral therapy, exercise, problem-solving therapy, behav-
ioral activation, and bright-light therapy. Overall, the meta-analysis showed a small effect for
cognitive behavioral therapy, with one study also showing that bright-light therapy was effec-
tive. Another 18 studies, which evaluated potential non-pharmacological interventions in the
community suitable for implementation, indicated that bibliotherapy, life-review, problem-
solving therapy, and cognitive behavioral therapy were effective at short-term follow-up.
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Discussion
We conclude that the effects of several treatments are promising, but need to be replicated
before they can be implemented more widely in primary care. Although more treatment
modalities were effective in a community setting, more research is needed to investigate
whether these treatments are also applicable in primary care.
Trial registration
PROSPERO CRD42016038442.
Introduction
Depression is a common disorder among older adults, with an estimated one-year prevalence
of 10% in primary care [1,2]. These older patients are most often treated in primary care [3],
and only a few are referred to specialist mental healthcare services [4,5]. This is consistent with
research indicating that older adults prefer to consult their general practitioner for mental
health problems [6,7]. If depression is treated, most of these patients will be treated with an
antidepressant [4]. However, depression in older adults often co-occurs with chronic somatic
disease [8] and in the context of polypharmacy [9]. Prescribing antidepressants therefore
increases the risk of adverse drug-related events [10], as evidenced by the fact that two-thirds
of elderly antidepressant users receive drugs that are either contraindicated or have the poten-
tial for moderate to major interactions [11,12]. Moreover, tricyclic antidepressants, and to a
minor degree newer agents like SSRIs, often have anticholinergic and sedative effects that are
associated with physical and cognitive impairment [13–15].
Evidence-based non-pharmacological treatment options are needed for the treatment of
depression in older adults, particularly in primary care. Despite this, the most recent system-
atic review focusing on the treatment for late-life depression in primary care was performed
more than 15 years ago [16]. Although other systematic reviews and meta-analyses focusing
on the psychological treatment of late-life depression have concluded that psychological thera-
pies seem effective [17–20], these had limitations precluding the generalization of their results
to primary care settings. First of all, all reviews included studies conducted in clinical settings.
Moreover, the most recently conducted review included only six RCTs. Three of these six
RCTs were conducted in a primary care setting, with even two of them relying on an academic
team to provide the intervention at home [18]. Furthermore, two previously conducted
reviews also included middle-aged adults (50+) [17,19]. Since, depression may be more hetero-
geneous in primary care, and treatment may be less structured, this precludes generalizability
of the results of these previous systematic reviews to primary care. Given that primary care is
the predominant setting in which depression in older adults is treated, it is essential that an
up-to-date summary is available to inform practitioners of the evidence base for non-pharma-
cological treatments in this setting.
We aimed to present an overview of the evidence for non-pharmacological treatment
options for depression in older adults (60+) within primary care, to provide up-to-date, evi-
dence-based information to inform primary care physicians about possible alternatives for
antidepressant treatment with its side-effects, interactions and contribution to polypharmacy.
Non-pharmacological treatments for late-life depression
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Methods
Search strategy
The protocol for this systematic review was registered at PROSPERO (CRD42016038442). We
performed an extensive search in the databases of PubMed, PsychINFO, and the Cochrane
Central Register of Controlled Trials. We used the following search terms: (general practice
OR synonym) AND (depressive disorder OR synonym) AND (aged OR synonym) AND
(non-pharmacological treatment OR synonym). Free text words and index terms were used
(MeSH for PubMed and Thesaurus for PsychINFO). We searched for articles until the January
2nd, 2017. The full search strategies for the three databases are presented in S1 Appendix.
Identification and selection of studies
To be as comprehensive as possible, we decided not to restrict the searches to randomized con-
trolled trials (RCTs). Results of other study types (e.g. cohort studies) were used to identify
promising therapeutic strategies subject to future research. Therefore, we included all empiri-
cal studies that met the following criteria: (a) sample sizes5 patients; (b) depression as the
primary outcome; (c) a study population of adults aged60 years at the moment of inclusion
(or there were adequately reported sub-analyses of adults60 years); (d) was conducted in a
primary care or community setting; and (e) reported non-pharmacological treatments applica-
ble in these settings. We set no language or date restrictions.
Depression was defined as either an identified depressive disorder according to DSM or
ICD criteria determined by a validated diagnostic interview or instrument, or as an elevated
score on a screening tool. Since there is no known golden standard for the identification of
depression in later life, we decided to include all studies focusing on depression, regardless of
their depression inclusion criterion. The age cut-off of 60 was used, because this is the mostly
used cut-off for late-onset depression [21]. In addition, the earlier review regarding treatment
of depression in primary care [16] also included studies focusing on adults aged 60+.
Studies were excluded if they met the following criteria: (a) included bipolar disorder, psy-
chotic depression, or depression with suicide ideation, which are considered indicative for
referral to secondline treatment [22]; (b) focused on caregivers instead of patients; (c) studied
the effect of a non-pharmacological intervention as an adjunct to pharmacotherapy; (d) stud-
ied the effect of service-level intervention, such as collaborative or stepped care; or (e) studied
the effect of an intervention to prevent depression.
Studies were independently screened and selected for inclusion by two authors (FH and
BM). First, titles were screened to exclude irrelevant papers, and the remaining abstracts were
then scrutinized in detail. Of the potentially relevant papers, full texts were retrieved to deter-
mine whether the inclusion criteria were met. In cases of disagreement, consensus was reached
based on discussion and, if necessary, consultation with a third author (PV). We searched for
additional articles by studying published study protocols lacking published follow-up data, by
checking the reference lists of the included publications and of relevant systematic reviews and
meta-analyses [17–20], and by screening conference abstracts. If necessary, corresponding
authors of possible relevant papers were contacted.
Analysis
Quality assessment. The Cochrane risk of bias tool was used for the quality assessment of
included RCTs [23]. This was done independently by two authors (FH and BM). Studies were
not excluded based on the quality assessment, but the quality was considered when comparing
Non-pharmacological treatments for late-life depression
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the different studies, when interpreting the results, and when recommendations for future
studies were formulated.
Data extraction. Two authors (FH and BM) independently extracted data from all
included studies. The following data were extracted: year of study, study design, sample size,
setting (primary care, community), population characteristics (age, gender, comorbidity),
treatment type and characteristics (e.g. individual/group, number of sessions), diagnosis at
baseline and diagnostic tool, main result, percentage that declined participation, duration of
follow-up, percentage lost to follow-up, and percentage that adhered to treatment. Included
studies were classified to the setting in which they were conducted, namely primary care set-
ting or community setting. Studies were considered primary care studies if the study recruited
participants in primary care and the intervention was delivered in that setting. Studies were
considered community studies when participants were recruited from the community, for
example, by means of self-referral.
The results were then summarized into the following three categories: (1) mean change,
defined as the difference in depressive symptoms between baseline and follow-up measure-
ment; (2) responders, defined as a50% symptom reduction in the outcome measure between
baseline and follow-up (unless stated otherwise); and (3) remission from depression at follow-
up measurement. The definition of remission differed between studies. The mean change in
depressive symptom scores was the primary outcome of this review.
Analysis. We narratively reviewed the included studies by type of treatment, with the
results stratified by setting (primary care or community). Given that most studies in primary
care have focused on the effect of cognitive behavior therapy (CBT), we chose to perform a
meta-analysis for the effect of this intervention in the primary care setting. Because of expected
heterogeneity of the studies, a random-effects model was used to pool the effect of CBT on
depression. We calculated the standardized mean differences (SMD) using the mean scores
and standard deviations immediately after treatment and at long-term follow-up for the inter-
vention and control groups in the studies included in the meta-analysis. If these data were not
available in the original articles, they were calculated by the researchers, using the published
data. If studies varied in measurement time points during long-term follow-up, we calculated
the SMDs for the points closest to 6 months. Statistical heterogeneity was evaluated by the chi-
square and I2 tests. Inter-study heterogeneity was considered significant for p< 0.1 and I2 >
50%. The meta-analysis was conducted using Review Manager (Version 5.3. Copenhagen: The
Nordic Cochrane Centre, The Cochrane Collaboration, 2014).
Results
Selection of studies and characteristics of included studies
Fig 1 summarizes the process of study inclusion. In total, 4027 references were screened and
273 full text papers were retrieved, of which 17 were identified through cited reference search.
Of these, 31 were included that consisted of 29 different studies (27 RCTs, two cohort studies).
Of two RCTs two references of each were included, one reporting short-term follow-up and
the other long-term follow-up. Eleven primary care studies and 18 community studies were
included.
Table 1 shows the characteristics of the 11 included studies that were conducted in primary
care settings (10 RCTs, 1529 patients; 1 cohort study, 14 patients). The interventions studied
included CBT (n = 5), exercise (n = 2), problem-solving therapy (PST; n = 1), a combination
of CBT and bibliotherapy (n = 1), behavioral activation (BA; n = 1), and bright-light therapy
(n = 1). Follow-up ranged from 1 week up to 12 months.
Non-pharmacological treatments for late-life depression
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Table 2 shows the characteristics of the 18 studies recruiting in the community, most of
which depended on self-referral by participants (17 RCTs, 1041 patients; 1 cohort study, 22
patients). The studied treatment modalities were CBT (n = 3), bibliotherapy (n = 4), life-review
(n = 3), exercise (n = 4), PST (n = 3), and receiving postcards (n = 1). In addition, 1 study com-
pared cognitive therapy, behavioral therapy, and brief psychodynamic therapy with patients
on a waiting list. Follow-up period ranged from 4 weeks to 2 years.
Outcome data of primary care studies
The outcome data for studies conducted in a primary care setting are presented in Table 3, and
the quality assessments with corresponding scores on the subscales are presented in Fig 2. The
results of the meta-analysis are summarized in Fig 3.
Cognitive behavioral therapy. Five studies assessed the effect of CBT on depression in
older adults: three assessed the effect of CBT alone [25,28,31], one assessed its use in combina-
tion with self-management [29], and one compared CBT with clinical case-management [24].
CBT was delivered individually in three out of the five studies [28,29,31], and as a group ther-
apy in the other two [24,25].
CBT delivered as individual therapy was more effective in reducing depressive symptoms at
4 and 12 months’ follow-up compared with both control groups (talking control and care as
usual) [31]. In a study where CBT was delivered by individual therapy, CBT was not effective
at reducing depressive symptoms immediately after treatment or at 3 and 6 months’ follow-up
[28]. Equally, in another study where CBT was delivered by group therapy, it was no more
effective in achieving response (determined by a decrease of5 points in the PHQ-9 [Patient
Health Questionnaire]) compared with care as usual at 12 weeks’ follow-up [25]; however, this
Fig 1. PRISMA flow diagram of study selection.
https://doi.org/10.1371/journal.pone.0184666.g001
Non-pharmacological treatments for late-life depression
PLOS ONE | https://doi.org/10.1371/journal.pone.0184666 September 22, 2017 5 / 20
Ta
bl
e
1.
Ch
ar
ac
te
ris
tic
s
o
fs
tu
di
es
co
n
du
ct
ed
in
pr
im
ar
y
ca
re
.
St
ud
y
(ye
ar)
De
si
gn
Se
tti
ng
(co
un
try
)
Di
ag
no
st
ic
in
cl
us
io
n
cr
ite
rio
n
In
te
rv
en
tio
n
N
Co
nt
ro
l(i
f
ap
pl
ic
ab
le
)
N
M
od
e
o
ft
he
ra
py
A
ge
m
ea
n
(m
in)
Fe
m
al
e
(%
)
A
nt
id
ep
re
ss
an
tt
he
ra
py
Sp
ec
ifi
c
ba
se
lin
e
ch
ar
ac
te
ris
tic
s
De
cl
in
ed
pa
rti
ci
pa
tio
n
(%
)
Fo
llo
w
-u
p
pe
rio
d
Lo
ss
to
fo
llo
w
-
u
p
(%
)
A
dh
er
en
ce
(%
)
Ar
ea
n
(20
05
)
[24
]
RC
T
Pr
im
ar
y
ca
re
an
d
co
m
m
un
ity
(U
SA
)
M
ajo
rd
ep
re
ss
io
n
an
d
dy
st
hy
m
ia
(S
CI
D)
CB
T
20
1.
CC
M
;2
.
CC
M
+
CB
T
1. 27
;
2.
25
G
ro
up
th
er
ap
y,
by
ps
yc
ho
lo
gi
st
or
so
cia
l
w
or
ke
r,
18
se
ss
io
ns
/
w
ee
k
fo
r1
6
w
ee
ks
,2
h
ea
ch
65
.3
(60
+)
64
.2
%
AD
u
se
w
as
an
ex
cl
us
io
n
cr
ite
rio
n,
an
d
11
(22
%)
st
ar
te
d
Ad
si
m
m
ed
ia
te
ly
af
te
rt
re
at
m
en
t

$1
5,0
00
ho
us
eh
ol
d
in
co
m
e
14
%
Po
st
-
tre
at
m
en
t6
m
o
n
th
s
12
m
o
n
th
s
30
.6
%
38
.9
%
33
.3
%
(M
ea
ns
es
si
on
at
te
nd
an
ce
)C
BT
9.
8
CC
M
13
.9
CB
T
+
CC
M
9.
1
G
ar
cia
-
Pe
na
(20
15
)
[25
]
RC
T
Pr
im
ar
yc
ar
e
(M
ex
ico
)
De
pr
es
siv
e
sy
m
pt
om
s(
PH
Q-
9
cu
t-o
ff
2–
6)
CB
T
41
CA
U
by
G
P
41
G
ro
up
th
er
ap
yb
ya
n
u
rs
e
w
ith
10
/g
ro
up
;1
2
1.
5
h
se
ss
io
ns
/w
ee
k
70
.8
(60
+)
83
%
No
tr
ep
or
te
d
–
No
tr
ep
or
te
d
12
w
ee
ks
1.
2%
N
ot
re
po
rte
d
G
um
(20
16
)
[26
]
Pi
lo
t
Co
ho
rt
Pr
im
ar
yc
ar
e
(U
SA
)
M
ild
to
m
od
er
at
e
de
pr
es
siv
e
sy
m
pt
om
s(
PH
Q-
9
cu
t-o
ff
5–
14
)
Be
ha
vio
ra
l
ac
tiv
at
io
n
14
n
.a
.
n
.a
.
In
di
vid
ua
l,
1
se
ss
io
n,
90
m
in
ut
es
,b
yp
sy
ch
ol
og
ist
,
id
en
tif
yin
g
life
va
lu
es
,
se
le
ct
ac
tiv
itie
s,
an
d
es
ta
bl
ish
w
ee
kly
go
al
s.
FU
by
3
ph
on
e
ca
lls
70
.2
(60
+)
71
.4
%
Ba
se
lin
e:
35
.7
%
ps
yc
ho
tro
pi
cm
ed
ica
tio
n
–
47
.8
%
4
w
ee
ks
33
.3
%
N
ot
re
po
rte
d
Jo
lin
g
(20
11
)
[27
]
RC
T
Pr
im
ar
yc
ar
e
(N
eth
erl
an
ds
)
Su
bt
hr
es
ho
ld
de
pr
es
sio
n
(C
ES
-D
cu
t-o
ff
2–
6)
CB
T-
ba
se
d
bi
bl
io
th
er
ap
y
86
CA
U
84
In
di
vid
ua
lt
he
ra
py
,3
n
u
rs
e
vis
its
m
ax
1
h,
2
ph
on
e
ca
lls
81
.5
(75
+)
73
.5
%
No
tr
ep
or
te
d
–
15
.4
%
2
m
o
n
th
s
14
.1
%
41
%
co
m
pl
et
ed
fu
lli
nt
er
ve
nt
io
n
La
id
la
w
(20
08
)
[28
]
RC
T
Pr
im
ar
yc
ar
e
(S
co
tla
nd
,U
K)
M
DD
(S
AD
S-
L;
HD
RS

7<
24
;B
DI
-II

13
<
28
)
CB
T
21
CA
U
by
G
P
23
In
di
vid
ua
l,
by
ps
yc
ho
lo
gi
st
,m
ea
n
8
se
ss
io
ns
(ra
ng
e2
–1
7)
74
(60 +)
65
.9
%
2
CB
T
pa
rti
cip
an
ts
on
AD
.C
AU
co
ul
d
in
clu
de
AD
–
24
.3
%
Po
st
-
tre
at
m
en
t;
3
m
o
n
th
s;
6
m
o
n
th
s
13
.6
%
;
22
.7
%
;
43
.2
%
No
tr
ep
or
te
d
La
m
er
s
(20
10
)
[29
]
RC
T
Pr
im
ar
yc
ar
e
(N
eth
erl
an
ds
)
M
DD
(m
ild
/m
od
),
m
in
or
de
pr
es
sio
n,
dy
st
hy
m
ia
(M
IN
I)
Se
lf-
m
an
ag
em
en
t
+
CB
T
18
3
CA
U
17
8
In
di
vid
ua
lt
he
ra
py
,b
y
n
u
rs
e,
2–
10
se
ss
io
ns
du
rin
g
3
m
on
th
s
(m
ea
n
4),
1
h
ea
ch
70
.7
(60
+)
46
.5
%
AD
ex
cl
us
io
n
cr
ite
rio
n.
CA
U
co
ul
d
in
cl
ud
e
AD
:7
pa
rti
cip
an
ts
st
ar
te
d
du
rin
g
fo
llo
w-
up
16
5
D
M
an
d
17
6
CO
PD
pa
tie
nt
s
N
ot
re
po
rte
d
1
w
ee
k
3
m
o
n
th
s;
9
m
o
n
th
s
26
.9
%
;
33
.5
%
;
33
.2
%
No
di
ffe
re
nc
e
in
dr
op
ou
tr
at
e
be
tw
ee
n
IG
an
d
CG
Li
ev
er
se
(20
11
)
[30
]
RC
T
O
ut
pa
tie
nt
cli
ni
cs
an
d
ca
se
-fi
nd
in
g
via
G
P
of
fic
es
(N
eth
erl
an
ds
)
M
ajo
rd
ep
re
ss
io
n
(S
CI
D)
Br
ig
ht
-li
gh
t
th
er
ap
y
42
Di
m
re
d
lig
ht
47
In
di
vid
ua
l,
60
m
in
du
rin
g
ea
rly
m
or
ni
ng
,f
or
3
w
ee
k
69
.3
(60
+)
65
.2
%
R
an
do
m
iza
tio
n
st
ra
tif
ie
d
fo
rA
D.
IG
33
%
;C
G
38
%
–
11
.7
%
3
w
ee
ks
;6
w
ee
ks
5.
6%
;
16
.9
%
No
tc
le
ar
ly
re
po
rte
d
Se
rfa
ty
(20
09
)
[31
]
RC
T
Pr
im
ar
y
ca
re
(U
K)
De
pr
es
siv
e
di
so
rd
er
(G
eri
atr
ic
M
en
ta
l
St
at
e
an
d
Hi
st
or
y
an
d
Et
io
lo
gy
Sc
he
du
le
;B
DI
-II

14
)
CB
T
+
CA
U
70
1.
Ta
lki
ng
co
nt
ro
l
+
CA
U;
2.
CA
U
1. 67
;
2.
67
In
di
vid
ua
lt
he
ra
py
,b
y
ps
yc
ho
lo
gi
st
,m
ax
12
se
ss
io
ns
,5
0
m
in
ea
ch
.
As
ad
jun
ct:
“
Fe
el
in
g
G
oo
d”
ha
nd
bo
ok
74
.1
(65
+)
79
.4
%
In
clu
si
on
:s
ta
bl
e
do
se
fo
r

8
w
ee
ks
.B
as
el
in
e:
IG
25
.7
5%
TC
23
.8
%
CA
U
37
.3
%
CA
U
co
ul
d
in
clu
de
AD
–
19
.9
%
4
m
o
n
th
s;
10
m
o
n
th
s
13
.2
%
;
18
.1
%
M
ea
n
n
u
m
be
ro
f
se
ss
io
n
at
te
nd
ed
w
as
7
Si
m
s
(20
06
)
[32
]
Pi
lo
t
RC
T
Pr
im
ar
yc
ar
e
(A
us
tra
lia
)
De
pr
es
siv
e
sy
m
pt
om
s(
GD
Sc
ut
-
of
f
11
)
Pr
og
re
ss
ive
Re
sis
ta
nc
e
Tr
ai
ni
ng
14
Ad
vic
e
18
G
ro
up
/in
di
vid
ua
ln
ot
re
po
rte
d,
3/
we
ek
fo
r1
0
w
ee
ks
(m
ax
.3
0
se
ss
io
ns
)+
w
ee
kly
ph
on
e
m
on
ito
rin
g
74
.3
(65
+)
65
.6
%
AD
ex
cl
us
io
n
cr
ite
rio
n
–
N
ot
re
po
rte
d
10
w
ee
ks
;6
m
o
n
th
s
15
.8
%
58
%
m
et
ad
he
re
nc
e
cr
ite
rio
n
o
f6
0%
Si
ng
h
(20
05
)
[33
]
RC
T
Pr
im
ar
yc
ar
e
(A
us
tra
lia
)
M
ajo
r/m
ino
r
de
pr
es
sio
n,
dy
st
hy
m
ia
(in
str
um
en
tn
ot
re
po
rte
d;
G
DS
cu
t-
of
f
14
)
1.
Hi
gh
in
te
ns
ity
tra
in
in
g;
2.
Lo
w
in
te
ns
ity
tra
in
in
g
1. 20
;
2. 20
CA
U
by
G
P
20
G
ro
up
so
f1
–8
pa
rti
cip
an
ts
,3
/w
ee
k
du
rin
g
8
w
ee
ks
,s
es
sio
ns
of
60
m
in
.H
IG
H:
80
%
of
m
ax
lo
ad
.L
O
W
:2
0%
of
m
ax
lo
ad
69
.3
(60
+)
55
%
In
cl
us
io
n:
N
o
AD
pr
es
cr
ip
tio
n
w
ith
in
la
st
3
m
on
th
s
–
N
ot
re
po
rte
d
8
w
ee
ks
10
.0
%
H
IG
H:
95
%
–
10
0%
;L
O
W
:
99
%
–1
00
%
W
illi
am
s
(20
00
)
[34
]
RC
T
Pr
im
ar
yc
ar
e
(U
SA
)
M
in
or
de
pr
es
sio
n
an
d
dy
st
hy
m
ia
(P
RI
ME
-M
D)
PS
T
13
8
1.
pl
ac
eb
o;
2.
pa
ro
xe
tin
e
1. 14
0 2. 13
7
In
di
vid
ua
l,
by
ps
yc
ho
lo
gi
st
,s
oc
ia
l
w
or
ke
r,
or
co
un
se
lo
r.6
se
ss
io
ns
fo
r1
1
w
ee
k
(fir
st
fo
r1
h
th
en
30
m
in
ea
ch
)
71
(60 +)
41
.5
%
AD
pr
oh
ib
ite
d
in
PS
T
–
3.
9%
11
w
ee
ks
25
.1
%
81
,4
%
at
te
nd
ed

4
se
ss
io
ns
;
74
.9
%
co
m
pl
et
ed
al
l
se
ss
io
ns
AD
,A
nt
id
ep
re
ss
an
t;
BD
I,
Be
ck
De
pr
es
sio
n
In
ve
nt
or
y;
CA
U,
Ca
re
as
Us
ua
l;C
BT
,C
og
nit
ive
Be
ha
vio
rT
he
ra
py
;C
CM
,C
lin
ica
lC
as
e-
M
an
ag
em
en
t;
CE
S-
D,
Ce
nt
er
fo
rE
pi
de
m
io
lo
gi
c
St
ud
ie
sD
ep
re
ss
io
n
Sc
al
e;
CG
,C
on
tro
lG
ro
up
;C
O
PD
,C
hr
on
ic
O
bs
tru
ct
ive
Pu
lm
on
ar
yD
ise
as
e;
DM
,D
ia
be
te
sM
el
litu
s;
FU
,f
ol
lo
w-
up
;G
DS
,G
er
ia
tri
cD
ep
re
ss
io
n
Sc
al
e;
G
P,
G
en
er
al
Pr
ac
tit
io
ne
r;
HD
RS
,H
am
ilto
n
De
pr
es
sio
n
Ra
tin
g
Sc
al
e;
IG
,I
nt
er
ve
nt
io
n
G
ro
up
;M
DD
,M
ajo
rD
ep
re
ss
ive
Di
so
rd
er
;M
IN
I,
M
in
iI
nt
er
na
tio
na
lN
eu
ro
ps
yc
hi
at
ric
In
te
rv
ie
w
;n
.a
.,
n
o
t
ap
pl
ica
bl
e;
PH
Q-
9,
Pa
tie
nt
He
al
th
Qu
es
tio
nn
air
e;
RC
T,
R
an
do
m
ize
d
Co
nt
ro
lle
d
Tr
ia
l;
SC
ID
,S
tru
ct
ur
ed
Cl
in
ica
lIn
te
rv
ie
w
fo
rD
SM
Di
so
rd
er
s;
SA
DS
-L
,S
ch
ed
ul
e
fo
rA
ffe
ct
ive
Di
so
rd
er
sa
nd
Sc
hi
zo
ph
re
nia
–L
ife
tim
e
ve
rs
io
n;
UK
,U
ni
te
d
Ki
ng
do
m
;U
SA
,U
ni
te
d
St
at
es
of
Am
er
ica
.
h
tt
p
s:
//
d
o
i.o
rg
/1
0
.1
3
7
1
/jo
u
rn
al
.p
o
n
e.
0
1
8
4
6
6
6
.t
0
0
1
Non-pharmacological treatments for late-life depression
PLOS ONE | https://doi.org/10.1371/journal.pone.0184666 September 22, 2017 6 / 20
Ta
bl
e
2.
Ch
ar
ac
te
ris
tic
s
o
fi
nc
lu
de
d
st
ud
ie
s
co
n
du
ct
ed
in
co
m
m
u
n
ity
se
tti
ng
s.
St
ud
y
(ye
ar)
De
si
gn
Se
tti
ng
(co
un
try
)
Di
ag
no
st
ic
in
cl
us
io
n
cr
ite
rio
n
In
te
rv
en
tio
n
N
Co
nt
ro
l(i
f
ap
pl
ic
ab
le
)
N
M
od
e
o
ft
he
ra
py
Ag
e
m
ea
n
(m
in)
Fe
m
al
e
(%
)
A
nt
id
ep
re
ss
an
t
th
er
ap
y
Sp
ec
ifi
c
ba
se
lin
e
ch
ar
ac
te
ris
tic
s
De
cl
in
ed
pa
rti
ci
pa
tio
n
(%
)
Fo
llo
w
-u
p
pe
rio
d
Lo
ss
to
fo
llo
w
-u
p
(%
)
Ad
he
re
nc
e
(%
)
Ch
an
(20
13
)
[35
]
RC
T
Co
m
m
un
ity
(S
ing
ap
ore
)
M
ild
to
m
od
er
at
e
de
pr
es
siv
e
sy
m
pt
om
s(
GD
S
cu
t-o
ff

4)
Li
fe
-re
vie
w
14
No
ne
12
Cr
ea
tin
g
a
life
-s
to
ry
bo
ok
,i
nc
lu
di
ng
pe
rs
on
al
ph
ot
os
.5
se
ss
io
ns
,3
0–
45
m
in
ea
ch
69
.7
(60
+)
80
.8
%
No
tr
ep
or
te
d
Sa
m
pl
in
g
th
ro
ug
h
re
se
ar
ch
er
pe
rs
on
al
n
et
w
or
k
20
.7
%
8
w
ee
ks
0%
N
ot
re
po
rte
d
Ci
ec
ha
no
ws
ki
(20
04
)[3
6]
RC
T
Co
m
m
un
ity
se
ni
or
se
rv
ice
ag
en
cie
s
(U
SA
)
M
in
or
de
pr
es
sio
n
an
d
dy
st
hy
m
ia
(S
CI
D)
PS
T+
So
cia
l
ac
tiv
itie
s
+
M
od
er
at
e
ph
ys
ica
la
ct
ivi
ty
72
CA
U
66
In
di
vid
ua
l,b
y
so
cia
l
w
or
ke
r,
8
se
ss
io
ns
du
rin
g
19
w
ee
k,
50
m
in
.
Fo
llo
we
d
by
br
ie
fp
ho
ne
co
nt
ac
t
73
(60 +)
79
%
Ba
se
lin
e:
IG
40
%
;C
G
30
%
D
ur
in
g
st
ud
y:
st
ar
te
d
AD
IG
7;
CG
4
St
op
pe
d
AD
5
IG
;5
CG
8
do
sa
ge
ad
jus
ted
–
8%
6
m
o
n
th
s;
12
m
o
n
th
s
5.
1%
;
8.
0%
M
ed
ia
n:
8.
0
vi
si
ts
Fl
oy
d
(20
04
,
20
06
)[3
7,
38
]
RC
T
Co
m
m
un
ity
(U
SA
)
M
in
or
an
d
m
ajo
r
de
pr
es
sio
n,
dy
st
hy
m
ia
(H
RD
S
cu
t-o
ff

10
)
1.
Bi
bl
io
th
er
ap
y;
2.
Co
gn
itiv
e
ps
yc
ho
th
er
ap
y
1.
16
2.
16
W
ai
tin
g
lis
t(4
w
ee
ks
)
14
1.
Bo
ok
“
Fe
el
in
g
G
oo
d,
”
re
ad
+
ho
m
ew
or
k
ex
er
cis
es
,<
1m
on
th
.
W
ee
kly
ph
on
e
ca
lls
.2
.
In
di
vid
ua
l,
by
cli
ni
ca
l
ps
yc
ho
lo
gy
gr
ad
ua
te
st
ud
en
ts
,1
2–
20
se
ss
io
ns
,1
–2
/w
ee
k
68
.0
(60
+)
76
.1
%
In
clu
si
on
:s
ta
bl
e
do
se
fo
r
3
m
on
th
s
Ba
se
lin
e:
26
%
Se
lf-
re
fe
rra
l
12
.6
%
Po
st
-
tre
at
m
en
t;
3
m
o
n
th
s
(IG
o
n
ly)
;2
ye
ar
s
(IG
o
n
ly)
30
.4
%
;
43
.5
%
;
25
.8
%
(el
igi
ble
N
=
31
)
Bi
b:
Av
er
ag
e
25
4
pa
ge
sr
ea
d.
CP
:
80
.2
%
o
f
ho
m
ew
or
k
as
si
gn
m
en
ts
co
m
pl
et
ed
Hu
an
g
(20
15
)
[39
]
RC
T
Co
m
m
un
ity
(T
aiw
an
)
De
pr
es
siv
e
sy
m
pt
om
s(
GD
S
cu
t-o
ff

5)
1.
Ex
er
cis
e
(P
FE
);
2.
CB
T
1.
19
2.
18
CA
U
20
1.
G
ro
up
th
er
ap
y,
2–
4
pe
rg
ro
up
,3
/w
ee
kd
ur
in
g
12
w
ee
ks
,5
0m
in
pe
r
se
ss
io
n,
by
fit
ne
ss
in
st
ru
ct
or
.G
oa
l:1
50
m
in
/
w
ee
k.
2.
G
ro
up
th
er
ap
y,
3–
5
pe
rg
ro
up
,1
2
w
ee
kly
se
ss
io
ns
,6
0–
80
m
in
ea
ch
,b
yg
er
ia
tri
c
n
u
rs
e
76
.5
(65
+)
52
.6
%
No
AD
at
in
clu
si
on
or
st
ar
tin
g
AD
du
rin
g
fo
llo
w-
up
–
35
.8
%
Po
st
-
tre
at
m
en
t;
3
m
o
n
th
s;
6
m
o
n
th
s
0%
PF
E
go
al
ac
hi
ev
em
en
t
po
st
-tr
ea
tm
en
t
10
0%
;3
m
o
n
th
s
63
.2
%
;6
m
o
n
th
s
47
.4
%
.C
BT
:
u
n
kn
ow
n
Im
ai
(20
15
)
[40
]
RC
T
Co
m
m
un
ity
(Ja
pa
n)
De
pr
es
siv
e
sy
m
pt
om
s(
GD
S
cu
t-o
ff

4)
Re
ce
ivi
ng
po
st
ca
rd
s
93
No
ne
91
Re
ce
ivi
ng
po
st
ca
rd
s,
1/
m
on
th
du
rin
g
8
m
on
th
s.
Ha
nd
wr
itt
en
m
es
sa
ge
+
co
m
pu
te
rp
rin
te
d
ge
ne
ra
lm
es
sa
ge
81
(65 +)
73
.4
%
Ba
se
lin
e:
IG
8.
9%
;
CG
8.
3%
N
o
re
st
ric
tio
ns
re
ga
rd
in
g
tre
at
m
en
to
ut
si
de
tri
al
“
So
cia
lis
ol
at
io
n”
de
fin
ed
by
ea
tin
g
m
ea
ls
al
on
e
54
.8
%
12
–1
4
m
o
n
th
s
20
.7
%
N
ot
ap
pl
ica
bl
e
Ki
os
se
s
(20
10
)
[41
]
RC
T
Co
m
m
un
ity
(U
SA
)
M
DD
(S
CI
D,
HA
M
-D
cu
t-o
ff

17
)
Pr
ob
le
m
Ad
ap
ta
tio
n
Th
er
ap
y
15
Su
pp
or
tiv
e
th
er
ap
y
15
PS
T
m
od
ifie
d
fo
r
co
gn
itiv
e
im
pa
ire
d.
In
di
vid
ua
l,d
ur
in
g
12
w
ee
ks
,h
om
e-
de
liv
er
ed
,
by
th
er
ap
ist
79
.4
(65
+)
70
.0
%
In
cl
us
io
n:
Ps
yc
ho
tro
pi
c
m
ed
ica
tio
n
st
ab
le
do
se
fo
r
8
w
ee
ks
.
Ba
se
lin
e:
78
.7
%
on
AD
in
bo
th
gr
ou
ps
Co
gn
itiv
e
im
pa
irm
en
td
ef
ici
t
(D
RS

30
)&
im
pa
irm
en
t
iA
D
L
1
Se
lf-
re
fe
rra
l
13
.5
%
6
w
ee
ks
;1
2
w
ee
ks
(po
st-
tre
at
m
en
t)
10
.0
%
;
16
.7
%
No
tr
ep
or
te
d
Ki
os
se
s
(20
15
[42
])
RC
T
Co
m
m
un
ity
ag
en
cie
s
(U
SA
)
M
ajo
rd
ep
re
ss
io
n
(S
CI
D)
Pr
ob
le
m
Ad
ap
ta
tio
n
Th
er
ap
y
37
Su
pp
or
tiv
e
th
er
ap
y
co
gn
itiv
e
im
pa
irm
en
t
37
Pr
ob
le
m
-s
ol
vin
g
ap
pr
oa
ch
,in
di
vid
ua
l,
by
ps
yc
ho
lo
gi
st
/s
oc
ia
l
w
or
ke
r/
M
D.
12
se
ss
io
ns
1/
we
ek
80
.9
(65
+)
74
.3
%
In
cl
us
io
n:
st
ab
le
do
se
fo
r
6
w
ee
ks
.
Ba
se
lin
e:
IG
65
%
;C
G
62
%
At
le
as
tm
ild
co
gn
itiv
e
de
fic
it
(D
RS

7)
&
im
pa
irm
en
t
iA
DL

1
N
ot
re
po
rte
d
12
w
ee
ks
14
.9
%
N
ot
re
po
rte
d
M
cN
ei
l(1
99
1)
[43
]
RC
T
Co
m
m
un
ity
(C
an
ad
a)
M
od
er
at
e
de
pr
es
sio
n
(B
DI
cu
t-o
ff
12
–2
4)
Ex
er
cis
e
? (to
tal
30
)
1.
So
cia
l
co
nt
ac
t
co
nt
ro
l;
2.
W
ai
tin
g
lis
t(6
w
ee
ks
)
? (to
tal
30
)
W
al
kin
g
at
vig
or
ou
s
pa
ce
,3
x/
we
ek
,2
0–
40
m
in
,d
ur
in
g
6
w
ee
ks
.
2x
/w
ee
ka
cc
om
pa
ni
ed
w
ith
u
n
de
rg
ra
du
at
e
ps
yc
ho
lo
gi
st
72
.5 (?)
?
No
tr
ep
or
te
d
–
N
ot
re
po
rte
d
10
w
ee
ks
0%
N
ot
re
po
rte
d
M
os
s
(20
12
)
[44
]
RC
T
Co
m
m
un
ity
(U
SA
)
De
pr
es
siv
e
sy
m
pt
om
s(
GD
S
cu
t-o
ff

5)
Be
ha
vio
ra
l
Ac
tiv
at
io
n
Bi
bl
io
th
er
ap
y
13
W
ai
tin
g
lis
t
(4w
ee
ks
)
13
In
di
vid
ua
l,s
el
f-s
tu
dy
in
w
or
kb
oo
k,
w
ee
kly
ph
on
e
ca
lls
77
.5
(65
+)
76
.9
%
In
cl
us
io
n:
st
ab
le
do
se
fo
r
1
m
on
th
–
5.
5%
8
w
ee
ks
30
.8
%
69
%
co
m
pl
et
ed
fu
llt
re
at
m
en
t
pr
og
ra
m
Pr
es
ch
l(2
01
2)
[45
]
RC
T
Co
m
m
un
ity
(S
wit
ze
rla
nd
)
Su
bs
yn
dr
om
ic
an
d
m
od
er
at
e
de
pr
es
sio
n
(B
DI
cu
t-o
ff
10
–2
8)
Li
fe
-re
vie
w
21
W
ai
tin
g
lis
t(6
w
ee
ks
)
19
In
di
vid
ua
l,
by
ps
yc
ho
lo
gi
st
,6
se
ss
io
ns
,1
/w
ee
kd
ur
in
g
6
w
ee
ks
.F
ac
e
to
fa
ce
an
d
co
m
pu
te
r
in
te
rv
en
tio
n
70
(65 +)
66
.7
%
Ba
se
lin
e:
IG
28
.6
%
CG
41
.2
%
Se
lf-
re
fe
rra
l
No
tr
ep
or
te
d
6
w
ee
ks
;3
m
o
n
th
s
(IG
o
n
ly)
10
.0
%
;
33
.3
%
No
tr
ep
or
te
d
Ro
se
nb
er
g
(20
10
)[4
6]
Pi
lo
t
Co
ho
rt
Se
ni
or
co
m
m
un
ity
ce
nt
er
/
re
tir
em
en
t
co
m
m
un
itie
s
(U
SA
)
Su
bs
yn
dr
om
ic
de
pr
es
sio
n
(M
IN
I)
Ex
er
cis
e
(N
int
en
do
W
ii
ga
m
in
g)
22
n
.a
.
n
.a
.
G
ro
up
/in
di
vid
ua
ln
ot
re
po
rte
d
fir
st
by
ph
ys
ica
l
tra
in
er
,s
ub
se
qu
en
tb
y
st
af
fm
em
be
rs
,3
x
35
m
in
ea
ch
w
ee
k,
du
rin
g
12
w
ee
ks
78
.7
(60
+)
68
.4
%
AD
ex
cl
us
io
n
cr
ite
rio
n
–
No
tr
ep
or
te
d
12
w
ee
ks
;
24
w
ee
ks
13
.6
%
;
22
.7
%
84
%
ad
he
re
nc
e
o
ft
ot
al
po
ss
ib
le
da
ys
Sc
og
in
(19
87
)
[47
]
RC
T
Co
m
m
un
ity
(U
SA
)
M
ild
to
m
od
er
at
e
de
pr
es
sio
n
(H
RS
D
cu
t-o
ff

10
)
1.
Co
gn
itiv
e
bi
bl
io
th
er
ap
y;
2.
Co
nt
ro
l
bi
bl
io
th
er
ap
y
(A
tte
nti
on
Co
nt
ro
l)
1.
10
2.
8
W
ai
tin
g
lis
t(4
w
ee
ks
)
11
1.
Bo
ok
“
Fe
el
in
g
go
od
,”
re
ad
<
1m
on
th
,w
ee
kly
ph
on
e
ca
lls
2.
Bo
ok
“
M
an
”s
se
ar
ch
fo
r
m
ea
ni
ng
,”
w
ee
kly
ph
on
e
ca
lls
71
.0
(60
+)
79
.3
%
Ba
se
lin
e:
20
.7
%
ps
yc
ho
tro
pi
cm
ed
.C
B
33
.3
%
AC
25
.0
%
W
ai
tin
g
lis
t9
.1
%
Se
lf-
re
fe
rra
l
N
ot
re
po
rte
d
Po
st
-
tre
at
m
en
t;
1
m
o
n
th
(IG
o
n
ly)
10
.3
%
;
31
.0
%
2
di
d
n
o
ts
ta
rt
a
bo
ok
,3
di
d
n
o
t
co
m
pl
et
e
a
bo
ok
(C
on
tin
ue
d)
Non-pharmacological treatments for late-life depression
PLOS ONE | https://doi.org/10.1371/journal.pone.0184666 September 22, 2017 7 / 20
Ta
bl
e
2.
(C
on
tin
ue
d)
St
ud
y
(ye
ar)
De
si
gn
Se
tti
ng
(co
un
try
)
Di
ag
no
st
ic
in
cl
us
io
n
cr
ite
rio
n
In
te
rv
en
tio
n
N
Co
nt
ro
l(i
f
ap
pl
ic
ab
le
)
N
M
od
e
o
ft
he
ra
py
Ag
e
m
ea
n
(m
in)
Fe
m
al
e
(%
)
A
nt
id
ep
re
ss
an
t
th
er
ap
y
Sp
ec
ifi
c
ba
se
lin
e
ch
ar
ac
te
ris
tic
s
De
cl
in
ed
pa
rti
ci
pa
tio
n
(%
)
Fo
llo
w
-u
p
pe
rio
d
Lo
ss
to
fo
llo
w
-u
p
(%
)
Ad
he
re
nc
e
(%
)
Sc
og
in
(19
89
,
19
90
)[4
8,
49
]
RC
T
Co
m
m
un
ity
(U
SA
)
M
ild
to
m
od
er
at
e
de
pr
es
sio
n
(H
RS
D
cu
t-o
ff

10
)
1.
Be
ha
vio
ra
l
bi
bl
io
th
er
ap
y;
2.
Co
gn
itiv
e
bi
bl
io
th
er
ap
y
1.
23
2.
22
W
ai
tin
g
lis
t(4
w
ee
ks
)
22
1.
Bo
ok
“
Co
nt
ro
lY
ou
r
De
pr
es
sio
n,
”r
ea
d
<
1m
on
th
,w
ee
kly
ph
on
e
ca
lls
.2
.B
oo
k
“
Fe
el
in
g
G
oo
d,
”r
ea
d
<
1m
on
th
,
w
ee
kly
ph
on
e
ca
lls
68
.3
(60
+)
85
.1
%
In
clu
sio
n:
st
ab
iliz
ed
on
ps
yc
ho
tro
pi
cs
.
Ba
se
lin
e:
34
.3
%
Se
lf-
re
fe
rra
l
N
ot
re
po
rte
d
Po
st
-
tre
at
m
en
t;
6
m
o
n
th
(IG
o
n
ly)
;2
ye
ar
s
(IG
o
n
ly)
7.
5%
;
34
.3
%
;
31
.8
%
(el
igi
ble
N
=
44
)
Bo
th
co
nd
itio
ns
:
av
er
ag
e
o
f8
5%
o
fb
oo
k
w
as
re
ad
Se
rra
no
(20
04
)
[50
]
RC
T
Co
m
m
un
ity
(S
pa
in)
Cl
in
ica
lly
sig
ni
fic
an
t
de
pr
es
siv
e
sy
m
pt
om
s
(C
ES
-D
cu
t-o
ff

16
)
Li
fe
-re
vie
w
25
CA
U
(by
so
cia
l
se
rv
ice
s)
25
In
di
vid
ua
l,
by
th
er
ap
ist
,4
se
ss
io
ns
,1
/w
ee
k
77
.2
(65
+)
76
.7
%
AD
ex
clu
si
on
cr
ite
rio
n
Se
lf-
re
fe
rra
l
18
.4
%
8
w
ee
ks
14
%
N
ot
re
po
rte
d
Si
ng
h
(19
97
)
[51
]
RC
T
Co
m
m
un
ity
M
ild
de
pr
es
siv
e
sy
m
pt
om
s(
BD
I
cu
t-o
ff
>
12
)
Ex
er
cis
e
17
He
al
th
ed
uc
at
io
n
pr
og
ra
m
15
G
ro
up
(1–
8i
nd
ivi
du
al
s),
hi
gh
in
te
ns
ity
pr
og
re
ss
ive
re
sis
ta
nc
e
tra
in
in
g,
du
rin
g
10
w
ee
ks
,3
da
ys
/w
ee
k,
45
m
in
pe
rs
es
sio
n,
by
pr
in
cip
al
in
ve
st
ig
at
or
71
(60 +)
62
.5
%
Ex
cl
us
io
n
if
on
AD
w
ith
in
la
st
3
m
on
th
s
Se
lf-
re
fe
rra
l
No
tr
ep
or
te
d
10
w
ee
ks
0%
IG
:9
3%
.C
G
:
95
%
Th
om
ps
on
(19
87
)[5
2]
RC
T
Co
m
m
un
ity
(U
SA
)
M
ajo
rd
ep
re
ss
io
n
(R
es
ea
rch
Di
ag
no
st
ic
Cr
ite
ria
)B
DI
cu
t-
of
f
17
;H
RS
D
cu
t-o
ff

14
1.
Co
gn
itiv
e
th
er
ap
y;
2.
Be
ha
vio
ra
l
th
er
ap
y;
3.
Br
ie
f
ps
yc
ho
dy
na
m
ic
th
er
ap
y
1.
27
2.
25
3.
24
W
ai
tin
g
lis
t(6
w
ee
ks
)
20
Al
l3
in
te
rv
en
tio
ns
:
In
di
vid
ua
lt
he
ra
py
,b
y
ps
yc
ho
lo
gi
st
,1
6–
20
se
ss
io
ns
,1
–2
/w
ee
k
67
.0
(60
+)
67
.4
%
In
clu
si
on
:s
ta
bi
liz
ed
fo
r
3
m
on
th
.
Ba
se
lin
e:
%
u
n
cle
ar
Se
lf-
re
fe
rra
l
N
ot
re
po
rte
d
M
id
-
tre
at
m
en
t;
Po
st
-
tre
at
m
en
t
(IG
o
n
ly)
Un
cle
ar
No
tr
ep
or
te
d
Ti
to
va
(20
15
)
[53
]
RC
T
Co
m
m
un
ity
(A
us
tra
lia
)
De
pr
es
siv
e
fe
el
in
gs
iC
BT
29
W
ai
tin
g
lis
t(8
w
ee
ks
)
25
In
di
vid
ua
l,
5
le
ss
on
s
du
rin
g
8
w
ee
ks
+
w
ee
kl
y
co
nt
ac
tw
ith
th
er
ap
ist
by
ph
on
e
or
e-
m
ai
l
65
(60 +)
74
.1
%
N
ot
re
po
rte
d
Se
lf-
re
fe
rra
l
N
ot
re
po
rte
d
Po
st
-
tre
at
m
en
t;
3
m
o
n
th
s
(IG
o
n
ly)
;1
2
m
o
n
th
s
(IG
o
n
ly)
13
.0
%
;
31
.0
%
;
34
.5
%
70
%
co
m
pl
et
ed
tre
at
m
en
tw
ith
in
th
e
8
w
k
co
ur
se
W
ut
hr
ich
(20
13
)[5
4]
RC
T
Co
m
m
un
ity
(A
us
tra
lia
)
DS
M
-IV
(su
b)
cli
ni
ca
lc
rit
er
ia
fo
r
bo
th
an
xie
ty
an
d
m
oo
d
di
so
rd
er
(A
DI
S
3)
CB
T
27
W
ai
tin
g
lis
t
(12
w
ee
ks
)
35
G
ro
up
th
er
ap
y,
12
w
ee
kl
ys
es
sio
ns
,2
h
ea
ch
,6
–8
pa
rti
cip
an
ts
pe
rg
ro
up
,b
y
ps
yc
ho
lo
gi
st
+
ho
m
ew
or
k
67
.4
(60
+)
64
.5
%
Ba
se
lin
e:
21
.0
%
on
ps
yc
ho
tro
pi
c
m
ed
ica
tio
n.
IG
22
.2
CG
20
.0
%
.
Pa
rti
ci
pa
nt
sw
er
e
as
ke
d
n
ot
to
ch
an
ge
m
ed
ica
tio
n
du
rin
g
tri
al
Co
m
or
bi
d
an
xi
et
y
di
so
rd
er
.S
el
f-
re
fe
rra
l
No
tr
ep
or
te
d
Po
st
-
tre
at
m
en
t;
3
m
o
n
th
s
(IG
o
n
ly)
24
.2
%
;
25
.9
%
M
ea
n
n
u
m
be
ro
f
se
ss
io
ns
at
te
nd
ed
9.
3
AD
,A
nt
id
ep
re
ss
an
t;
AC
,A
tte
nt
io
n
Co
nt
ro
l;A
DI
S,
An
xie
ty
Di
so
rd
er
In
te
rv
ie
w
Sc
he
du
le
;B
DI
,B
ec
k
De
pr
es
sio
n
In
ve
nt
or
y;
Bi
b,
Bi
bl
io
th
er
ap
y;
CB
,C
og
nit
iv
e
bi
bl
io
th
er
ap
y;
CB
T,
Co
gn
itiv
e
Be
ha
vio
rT
he
ra
py
;C
ES
-D
,
Ce
nt
er
fo
rE
pi
de
m
io
lo
gi
cS
tu
di
es
De
pr
es
sio
n
Sc
al
e;
CG
,C
on
tro
lG
ro
up
;C
P,
Co
gn
itiv
e
Ps
yc
ho
th
er
ap
y;
DR
S,
De
m
en
tia
R
at
in
g
Sc
al
e;
G
DS
,
G
er
ia
tri
cD
ep
re
ss
io
n
Sc
al
e;
iA
DL
,i
ns
tru
m
en
ta
lA
ct
ivi
tie
s
of
Da
ily
Li
fe
;H
AM
-D
Ha
m
ilto
n
Ra
tin
g
Sc
al
e
fo
rD
ep
re
ss
io
n;
HR
SD
,H
am
ilto
n
R
at
in
g
Sc
al
e
fo
rD
ep
re
ss
io
n
;i
CB
T,
In
di
vid
ua
l
Co
gn
itiv
e
Be
ha
vio
rT
he
ra
py
;I
G
,I
nt
er
ve
nt
io
n
G
ro
up
;M
IN
I,
In
te
rn
at
io
na
lN
eu
ro
ps
yc
hi
at
ric
In
te
rv
ie
w;
PF
E,
Ph
ys
ica
lF
itn
es
s
Ex
er
cis
e;
PS
T,
Pr
ob
le
m
-
So
lvi
ng
Th
er
ap
y;
RC
T,
Ra
nd
om
ize
d
Co
nt
ro
lle
d
Tr
ia
l;
SC
ID
,S
tru
ct
ur
ed
Cl
in
ica
lIn
te
rv
ie
w
fo
rD
SM
Di
so
rd
er
s;
US
A,
Un
ite
d
St
at
es
o
fA
m
er
ica
.
h
tt
p
s:
//
d
o
i.o
rg
/1
0
.1
3
7
1
/jo
u
rn
al
.p
o
n
e.
0
1
8
4
6
6
6
.t
0
0
2
Non-pharmacological treatments for late-life depression
PLOS ONE | https://doi.org/10.1371/journal.pone.0184666 September 22, 2017 8 / 20
later study did not report the mean change in depressive symptoms. In other research, clinical
case-management was more effective than CBT at 12 months’ follow-up [24]. By contrast,
CBT in combination with self-management was shown to reduce depressive symptoms at 3
and 9 months’ follow-up [29].
Fig 3 shows the results of the meta-analysis. Four out of the five studies focusing on CBT in
primary care could be included in the meta-analysis; the fifth study could not be included
because it did not report continuous baseline and follow-up data [25], and because the authors
Table 3. Outcomes by intervention and control groups (if applicable) for studies conducted in primary care.
Study
(year)
Treatment Outcome
measure
Follow-up Mean change* Responders** Remission
Arean
(2005) [24]
1.CBT; 2.CCM; 3.
CBT+CCM
HDRS Post-treatment (6
months); 6
months FU; 12
months FU
CBT -1.71 CCM -3.84 CBT+CCM -2.77;
n.s.; CBT -1.50 CCM -4.37 CBT+CCM
-4.81; n.s.; CBT +1.97 CCM -5.10 CBT
+CCM -8.49; CBT vs other p < .01
Not reported Not reported
Garcia-
Pena
(2015) [25]
CBT PHQ-9 12 weeks FU Not reported IG 56.1% and CG 30%; n.s.a Not reported
Gum
(2016) [26]
Behavioral
Activation
PHQ-9 4 weeks FU -4.28; p = .002 Not reported 57.1%b
Joling
(2011) [27]
CBT-based
bibliotherapy
CES-D 2 months FU IG: -4.57 and CG -4.78; p = .73 IG 46.9% and CG 43.6; p = .70c IG 36.4% and CG 30%; p
= .46d
Laidlaw
(2008) [28]
CBT HRSD
BDI-II
Post-treatment
(18 weeks); 3
months FU; 6
months FU
HRDS: IG -6.15 and CG -4.05; p = .15;
BDI-II: IG -10.2 and CG -6.25; p = .21;
HRDS: IG -6.25 and CG -5.1; p = .38;
BDI-II: IG -10.6 and CG -6.6; p = .17;
HRDS: IG -4.7 and CG -4.25; p = .63;
BDI-II: IG -9.05 and CG -4.4; p = .18
Not reported IG 70% and CG 40%;
p.06e; IG 80% and CG
50%; p = .047e; IG 55%
and CG 40%; p = .34e
Lamers
(2010) [29]
Self-management
+ CBT
BDI 1 week FU; 3
months FU; 9
months FU
IG -0.92 and CG -0.53; p = .19; IG -1.22
and CG -0.21; p < .05; IG -1.19 and CG
-0.30; p = .03
IG 6.3% and CG 7.4%; n.s.; IG
12.4% and CG 8.7%; n.s.; IG
17.5% and CG 7.3%; p = .02
Not reported
Lieverse
(2011) [30]
Bright-Light therapy HAM-D Post-treatment (3
weeks); 6 weeks
FU
IG -8.5 and CG -5.8; p = 0.03; IG -10.0
and CG -5.4; p = .001
IG 50% and CG 41%; p = .20;
IG 58% and CG 34%; p = .05
Not reported
Serfaty
(2009) [31]
CBT BDI-II 4 months FU; 10
months FU
CBT -8.9 TC -6.2 CAU -7.4; CBT vs other
p < .05; TC vs CAU n.s.; CBT -9.0 TC
-6.1 CAU -6.9; CBT vs other p < .05; TC
vs CAU n.s.
CBT 33% and TC 21% and
CAU 23%; p-value not reported
Not reported
Sims
(2006) [32]
Progressive
Resistance Training
GDS 10 weeks FU; 6
months FU
IG -0.41 and CG -0.22; n.s.; IG -1.14 and
CG -0.34; n.s.
Not reported Not reported
Singh
(2005) [33]
1. High intensity
training; 2. Low
intensity training
HRSD/GDS 8 weeks FU HRSD: HIGH -9.5 LOW -7.1 GP -5.3; p =
.14; GDS: HIGH -11.6 LOW -8.7 GP -4.7;
p = .006
HRSD: HIGH 61% LOW 29%
GP 21%; HIGH vs LOW p = .05;
HIGH vs GP p < .02; LOW vs
GP p = .56
Not reported
Williams
(2000) [34]
PST HSCL-D-20 Post-treatment
(11 weeks)
PST -0.52 paroxetine -0.61 placebo
-0.40; PST vs paroxetine p = .17; PST vs
placebo p = .13
Not reported Not reported
BDI, Beck Depression Inventory; CAU, Care as Usual; CBT, Cognitive Behavior Therapy; CCM, Clinical Case-Management; CES-D, Center for
Epidemiologic Studies Depression Scale; CG, Control Group; FU, Follow-Up; GDS, Geriatric Depression Scale; HAM-D Hamilton Rating Scale for
Depression; HDRS, Hamilton Depression Rating Scale; HSCL-D, Hopkins Symptom Checklist for Depression; IG, Intervention Group; n.s., not significant;
PHQ-9, Patient Health Questionnaire.
* Difference between baseline measurement and follow-up measurement;
**Defined as50% reduction in outcome measure unless stated otherwise;
a Defined as a decrease of5 points on the PHQ-9 after 12 weeks;
b Defined as a PHQ-9 score4;
c Defined as a decrease of5 points on the CES-D;
d Defined as a decrease of5 points or more on the CES-D and a post-test score <16;
e Determined by RDC (Research Diagnostic Categorization as <4 symptoms of depression)
https://doi.org/10.1371/journal.pone.0184666.t003
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Fig 2. Risk of bias assessment for the included randomized controlled trials. Based on the Cochrane
Collaboration’s tool for assessing risk of bias, + indicates low risk of bias,—indicates high risk of bias, and?
indicates unclear risk of bias.
https://doi.org/10.1371/journal.pone.0184666.g002
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could not be reached by e-mail. The meta-analysis demonstrated that CBT had no effect on
depression immediately after treatment (SMD -0.16 [-0.34–0.02], I2 = 0%, Z = 1.69, p = 0.09).
A statistical significant effect was found at 6 months’ follow-up, but the effect size was only
small (SMD -0.21 [-0.40 –-0.03], I2 = 0%, Z = 2.23, p = 0.03). No statistically significant hetero-
geneity was found between the studies (χ2 = 1.58 [p = 0.66] and 1.13 χ2 = [p = 0.77], respec-
tively; I2 = 0% in both analyses).
To summarize, CBT was effective in two of the five studies, of which one was assessed to
have the lowest risk of bias. This effect was confirmed in the meta-analysis at six months’ fol-
low-up. The two studies demonstrating a beneficial effect of CBT used individually delivered
treatment rather than group therapy.
Exercise. Two studies assessed the effect of exercise [32,33]. Compared to a control group
receiving information about exercise and local exercise options, progressive resistance training
was not more effective in reducing depressive symptoms at 10 weeks’ and 6 months’ follow-up
[32]. But, high and low intensity training were both more effective in reducing depressive
symptoms at 8 weeks’ follow-up based on self-reported, but not observer-rated, measures [33].
The risk of bias was assessed as moderate for both studies.
Other. Treatment modalities in the “other” category included PST, CBT-based bibliother-
apy, behavioral activation, and bright-light therapy; all four were delivered individually. Of the
two studies with a low risk of bias, bright-light therapy was effective [30], whereas PST was not
[34]. In a study of moderate quality, CBT-based bibliotherapy was shown to be no more effec-
tive than care as usual [27]. Behavioral activation, which was only studied in a pilot cohort,
was found to reduce symptoms of depression at 4 weeks’ follow-up [26].
Outcome data of studies in community settings
Outcome data for studies conducted in the community are presented in Table 4, and the qual-
ity assessment with corresponding scores on the subscales is presented in Fig 2.
Cognitive behavioral therapy. Three RCTs [39,53,54] studied the effect of CBT on
depressive symptoms. One RCT demonstrated that CBT group therapy was more effective
than remaining on a waiting list, but found no difference between the effects of CBT and exer-
cise [39]. Another RCT showed that, after treatment, CBT group therapy was effective at
reducing depressive symptoms among participants suffering from depression with comorbid
Fig 3. Forrest plot of the meta-analysis for studies of cognitive behavioral therapy in primary care.
Control condition entered in meta-analyses specified by study: Arean (2005) [24] used clinical case-
management; but, Laidlaw (2008) [28], Lamers (2010) [29], Serfaty (2009) [31] used care as usual. One of the
two reported outcome measurements by Laidlaw was used in the meta-analyses, namely HRSD.
https://doi.org/10.1371/journal.pone.0184666.g003
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Table 4. Outcomes among intervention and control groups (if applicable) for included studies conducted in community settings.
Study (year) Treatment Outcome
measure
Follow-up Mean change* Responders** Remission
Chan (2013)
[35]
Life-review GDS 8 weeks IG -5.4 CG -1.0; p < .001 Not reported Not reported
Ciechanowski
(2004) [36]
PST; Social activities;
Moderate physical activity
HSCL-20 6 months FU; 12
months FU
IG -0.59 and CG -0.03; p < .001; IG
-0.48 and CG -0.19; p = .03
IG 54% and CG 8%;
P < .001; IG 43% and
CG 15%; p < .001
IG 44% and CG 10%; p
< .001a
IG 36% and CG 12%; p
= .002a
Floyd (2004,
2006) [37,38]
1.Bibliotherapy (Bib); 2.
Cognitive psychotherapy
(CP)
HRSD/GDS Post-treatment (Bib 4
weeks; CP 12
weeks); 3 months FU
(IG only); 2 years FU
(IG combined)
HRSD: B -6.81 CP -10.62 CG
-0.29; GDS B -5.6 CP -11.68 CG
-0.79; B vs CG, CP vs CG, B vs CP
all p < .05; HRSD: B -12.56 CP
-6.22; GDS: B -8.46CP -10.06;
HRSD: further improvement for B p
< .05; CP n.s.; GDS: no change
compared with post-treatment for B
and CP; HRSD: -10.87; GDS:
-8.73; HRDS and GDS no change
compared with post-treatment
Not reported B 35%; CP 57%; n.s.b
Huang (2015)
[39]
1.Exercise (PFE); 2. CBT GDS Post-treatment (3
months FU); 3
months FU; 6 months
FU
PFE -4.0 CBT -3.5 CG -2.0; p =
.012; PFE -4.21 CBT 2.61 CG
-2.45; p = .12; PFE -3.84 CBT -3.0
CG -2.1; p = .20
Not reported PFE 57.9% CBT 61.1%
CG 30%c; PFE 68.4%
CBT 61.1% CG 45%c;
PFE 63.2% CBT 66.7%
CG 35%c
Imai (2015) [40] Receiving postcards GDS 12–14 months FU IG 0.5 and CG 0.7; n.s. Not reported Not reported
Kiosses (2010)
[41]
Problem Adaptation
Therapy
HAM-D 6 weeks FU; 12
weeks FU
IG -11.33 and CG -7.65; IG -13.48
and CG 8.65; p = .03
Not reported Not reported
Kiosses (2015)
[42]
Problem Adaptation
Therapy
MADRS 12 weeks FU Baseline scores IG 21.08; CG
21.41; p = .58; IG lower scores at
week 12; p = .001 (no mean
difference reported)
IG 66.7% and CG
32.3%; p = .007
IG 37.8% and CG
13.5%; p.02d
McNeil (1991)
[43]
Exercise BDI 10 weeks FU IG: -5.5; Attention Control -4.2; CG
-0.5; IG vs Attention Control p >
.05; IG vs CG p < .05; Attention
Control vs CG p < .05
Not reported Not reported
Moss (2012)
[44]
Behavioral Activation
Bibliotherapy
HRSD Post-treatment (4
weeks)
IG -5.77 and CG -1.15; p = .004 Not reported Not reported
Preschl (2012)
[45]
Life-review BDI Post-treatment (8
weeks); 3 months FU
(IG only)
IG -9.0 and CG -1.4; p < .01; IG
-10.3; p < .01
Not reported Not reported
Rosenberg
(2010) [46]
Exercise (Nintendo Wii
gaming)
QIDS Post-treatment (12
weeks); 24 weeks FU
-2.7; p = .004; -4.07; p = .001 (24 weeks FU) 53% Not reported
Scogin (1987)
[47]
Cognitive bibliotherapy HRSD/GDS/
BDI
Post-treatment (4
weeks); 1 month FU
(IG Only)
HRSD: CB -8.5 AC -2.5 CG +1.1; p
< .05; GDS: CB -5.8 AC -0.6 CG
0.0; p < .05; BDI CB -3.4 AC -1.7
CG -0.7; n.s.; HRSD: -6.3; GDS:
-5.2; BDI: -0.7; No change
compared with post-treatment; p >
.05
Not reported Not reported
Scogin (1989,
1990) [48,49]
1.Behavioral bibliotherapy;
2.Cognitive bibliotherapy
HRSD/GDS Post-treatment (4
weeks); 6 months FU
(IG only); 2 years FU
(IG combined)
HRSD: BB -8.1 CB -8.8 CG -0.5; p
< .05; GDS: BB -2.7 CB -5.6 CG
-0.5; p < .05; HRDS:BB -8.7 CB
-7.4; GDS: BB -5.2 CB -6.8; No
change compared with post-
treatment; p > .05; HRDS: -0.7;
GDS -3.2; HRDS: no change
compared with post-treatment;
GDS: further improvement in
bibliotherapy conditions (p < .05)
HRSD: IG 66%
(completers only) CG
19%e
Not clearly reported
Serrano (2004)
[50]
Life-review CES-D Post-treatment (8
weeks)
IG -10.25 and CG 0.0; p < .0001 Not reported Not reported
Singh (1997)
[51]
High intensity progressive
resistance training
BDI/HRSD/
GDS
Post-treatment (10
weeks)
BDI-: IG -11.5 and CG -4.6; p =
.002;HRSD: IG -7.0 and CG -2.5; p
= .008; GDS: IG -8.3 and CG -1.9;
p = .0004
HRDS: IG 59% and
CG 26%; p = .067
n.s.f
(Continued)
Non-pharmacological treatments for late-life depression
PLOS ONE | https://doi.org/10.1371/journal.pone.0184666 September 22, 2017 12 / 20
anxiety [54]. Individual CBT delivered through the internet was also more effective at reducing
depressive symptoms after treatment than care as usual [53]. In the latter RCT, this effect was
maintained at 3 months’ follow-up, although this was not compared to a control condition. In
summary, individual CBT tended to be an effective treatment for reducing depressive symp-
toms compared with inactive control conditions among older adults, but the risk of bias ran-
ged from low to moderate in the included studies.
Bibliotherapy. Four RCTs investigated the effect of individual bibliotherapy
[37,44,47,48], and had low to moderate risk of bias. All RCTs showed that bibliotherapy was
effective at reducing depressive symptoms at 4 weeks’ follow-up compared with remaining on
a waiting list and being given a control form of bibliotherapy.
Life-review. All three RCTs investigating the effect of individual life-review on depression
in older adults found a positive effect on depressive symptoms from 2 to 8 weeks’ follow-up
[35,45,50]. One RCT [45] also reported a further improvement of depressive symptoms at 3
months’ follow-up, but did not compare this with a control condition. The risk of bias did dif-
fer a little between the included studies, ranging from high to moderate.
Exercise. Three RCTs [39,43,51] investigated the effect of exercise on depressive symp-
toms, with risk of bias assessments ranging from high to moderate. Compared with an active
control group, one RCT did demonstrate an effect of exercise on depressive symptoms [51].
Table 4. (Continued)
Study (year) Treatment Outcome
measure
Follow-up Mean change* Responders** Remission
Thompson
(1987) [52]
1. Cognitive therapy (CT);
2. Behavioral therapy
(BT); 3. Brief
Psychodynamic therapy
(BPT)
BDI/HRSD;
Diagnostic
status (SADS-
change)
Mid-treatment (6
weeks); Post-
treatment (16 weeks)
BDI: IG (combined) -6.1 CG +1.2; p
< .001; HRSD: IG (combined) -5.1
CG -0.3; p < .001; BDI: CT -11.7 BT
-10.1 BPT -9.2; n.s.; HRSD: CT
-8.7 BT -10.4 BPT -9.0; n.s.
Not reported (Post-treatment) CT
52%, BT 57% BPT
47%; n.s.g
Titov (2015)
[53]
iCBT PHQ-9 Post-treatment (8
weeks); 3 months FU
(IG only); 12 months
FU (IG only)
IG -9.46 and CG -0.25; p < .001;
-8.05; no change compared with
post-treatment; -8.02; no change
compared with post-treatment
IG 68.7% and CG
5.8%; p < .001h
IG 68.7% and CG 0%; p
< .001i
Wuthrich (2013)
[54]
CBT GDS/CES-D Post-treatment (12
weeks); 3 months FU
(IG only)
GDS: IG -8.93 CG -1.97; p = .004;
CES-D: IG -13.03 CG -1.45; p =
.007; GDS: -8.3; CES-D -12.98;
GDS and CES-D: no change
compared with post-treatment
Unclear Not reported for
depression separately
AC, Attention Control; BDI, Beck Depression Inventory; CBT, Cognitive Behavior Therapy; CES-D, Center for Epidemiologic Studies Depression Scale;
CG, Control Group; FU, Follow-Up; GDS, Geriatric Depression Scale; HAM-D Hamilton Rating Scale for Depression; HRSD, Hamilton Rating Scale for
Depression; iCBT, Individual Cognitive Behavior Therapy; IG, Intervention Group; MADRS, Montgomery Asberg Depression Rating Scale; n.s., not
significant; PFE, Physical Fitness Exercise; PHQ-9, Patient Health Questionnaire; PST, Problem Solving Therapy; QIDS, Quick Inventory of Depressive
Symptomatology; SADS, Schedule for Affective Disorders and Schizophrenia.
* Difference between baseline and follow-up measurements;
**Defined as a50% reduction in outcome measures, unless stated otherwise
a Defined as a HSCL-20 score <0.5;
b Defined as a reduction of the HRSD11 and no longer having a major depressive episode, or as a HRDS <10;
c Defined as the absence of depressive symptoms;
d Remission defined as a MADRS score <7;
e Defined as scores outside the range of the dysfunctional population, and a change according to the reliable change index;
f Defined as change in diagnostic category;
g Defined as scores outside the range of the dysfunctional population, and scores with a reliable change from Time 1;
h Defined as a >5.20 reduction on the PHQ-9;
i Defined as reliable improvement and a score below the clinical cut-off (PHQ-9 <10)
https://doi.org/10.1371/journal.pone.0184666.t004
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However, although two other RCTs did find that exercise had an effect compared with inactiv-
ity, no difference was observed between the exercise group and the active controls in each
study (e.g., CBT [39] and social contact control [43]). In addition, one cohort study [46] stud-
ied the effect of exercise on depressive symptoms. It was not reported whether the intervention
was delivered as group or as individual therapy, but showed reduced depression scores at 12
and 24 weeks’ follow-up compared with baseline.
Problem-solving therapy. Three RCTs studied the effect of individually delivered PST
[36,41,42]. They all demonstrated that PST reduced depressive symptoms. Two of these RCTs
[36,42] delivered PST in community agencies, and one combined PST with engagement in
social activities [36]. The risk of bias varied from low to moderate.
Other. One RCT investigated the effect of receiving postcards on depressive symptom-
atology [55], but showed no effect at follow-up. Another RCT showed that three interventions
(cognitive therapy, behavioral therapy, and brief psychodynamic therapy) had beneficial effects
compared with controls (waiting list) [52] at 6 weeks (mid-treatment), but showed no differ-
ences between these three interventions after treatment (16 weeks). However, the effects of the
three interventions were not compared with the control group after treatment, because those
on the waiting list had started treatment.
Discussion
Summary of main findings
Of the five treatments studied in primary care, a meta-analysis on CBT yielded a significant
result, indicating its potential benefit in primary care settings. There was also a positive effect
with bright-light therapy, and although this is promising, it needs replication in a second trial
in primary care before recommendations for implementation can be made. Unfortunately, we
did not find convincing evidence in favor of exercise, PST, or behavioral activation for the
treatment of depressive symptomatology in primary care, but better quality research is needed
before we can reach any definitive conclusions. In addition, community-based studies showed
promising short-term results for bibliotherapy, life-review, PST, behavioral therapy, brief psy-
chodynamic therapy, and cognitive therapy, which might, therefore, be suitable for use as
treatment strategies in primary care.
Comparison with existing literature
Previous systematic reviews and meta-analyses focusing on the use of non-pharmacological
treatment for depression in older patients have reported different findings to those in our
review [17–20]. Two recent systematic reviews [18,20], for example, concluded that psycholog-
ical treatments may be feasible for late-life depression (65+), but they did not perform formal
meta-analyses. However, both of these reviews questioned the generalizability and efficacy
because of the wide diversity of interventions, the low number of studies per intervention, and
the poor quality of studies included. Moreover, neither review was limited to the primary care
setting, and studies were excluded if they had a low quality assessment, leading to the exclusion
of 73.9% [18] and 36.4% [20] of the identified studies, respectively. To be more comprehensive,
we decided not to restrict ourselves to RCTs and not to exclude studies based on the quality
assessment. This not only ensured that we could summarize all available evidence but also
enabled us to formulate explicit targets for future research, such as instances where an included
study was of poor quality but focused on a promising intervention.
Another two reviews included formal meta-analyses of the research [17,19], and they indi-
cated that psychological treatments were moderately effective in the treatment of late-life
depression. Specifically, one showed that CBT, life-review, and PST [17] were effective, while
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the other showed that CBT was more effective than a non-active control group [19]. However,
these meta-analyses included studies conducted in clinical settings and with middle-aged par-
ticipants (50/55+). These differences might explain why we could not replicate the finding that
PST was an effective treatment for late-life depression in primary care; also, it should be noted
that life-review therapy has been studied as treatment for late-life depression in primary care
to date. Nonetheless, we confirmed the positive results for life-review and PST on depressive
symptoms in community settings. We could also replicate the finding that CBT was an effec-
tive treatment modality for late-life depression at 6 months’ follow-up, though with a small
effect size (SMD -0.21 [-0.40 to -0.03]) comparable to that reported in one of the previous stud-
ies [17]. The other meta-analysis demonstrated a much larger effect size (-1.35) when CBT was
compared with inactive controls, but did not find an effect when comparing CBT to active
controls [19]. The fact that we analyzed the effect of CBT compared with both active and inac-
tive controls might explain this difference. Although one might question the clinical relevance
of this small effect of CBT, it might be partly caused by a floor-effect of treatment associated
with milder forms of depression as seen and treated within primary care.
Another systematic review found that physical exercise may be effective for late-life depres-
sion [56]. We could not replicate this finding, irrespective of the quality assessments of these
studies, but it should be noted that the previously conducted review included studies recruiting
non-depressed adults, and that none of the studies included in the earlier review [56] was con-
ducted in a primary care setting.
Several differences can be seen when comparing the studies conducted in primary care with
those conducted in the community. First, although more treatment modalities have been stud-
ied in community settings, it is questionable whether these treatment modalities are applicable
in general practice. For example, creating a life-story book with personalized pictures [35] is
overly time-consuming for most GPs or practice nurses. Second, the follow-up periods of the
community-based studies were shorter than those conducted in primary care. Because none of
the studies included a control condition beyond the assessment when treatment ended, no
data is available on the sustainability of the effects. Third, most of the community studies only
included self-referred participants, thereby introducing selection bias. Self-referred partici-
pants show the initiative to seek out interventions targeting depression, whereas in general,
depressed older adults are more likely to be reluctant to seek help [57]. This purported selec-
tion bias might also explain some of the low percentages lost to follow-up in the self-referral
studies performed in the community. Although it is conceivable that community-based inter-
ventions would also be effective in primary care, further research is needed to confirm this
assumption. Finally, among the therapist-guided interventions, almost half were delivered by a
postgraduate therapist or clinical psychologist in the community studies, while only one-third
included a psychologist in the primary care studies. Because it is questionable whether clinical
psychology services could be successfully embedded in general practice, due for example to
higher costs for patients and/or insurances, future research should determine whether these
interventions can be successfully given by a practice nurse or other allied healthcare
professionals.
Several non-pharmacological treatments for late-life depression studied a community set-
ting seem promising for implementation in primary care. First of all, PST demonstrated a ben-
eficial effect in the community [36,41,42], but the only RCT conducted in primary care
demonstrated no effect on depressive symptoms [34]. However, the risk of bias was lower in
two of the community studies [36,42] compared with the study conducted in primary care
[34], and among middle-aged adults the effectiveness of PST in primary care has been con-
firmed [58]. Due to the positive results of PST in the community setting and among middle-
aged adults, we recommend a second RCT in primary care focusing on PST with a longer
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follow-up duration than the study included in our review (11 weeks) [34]. Moreover, the
control group in this primary care study [34] existed of paroxetine or a placebo, while an atten-
tion control form of therapy would have been more adequate. Furthermore, bibliotherapy
[37,44,47,48] and life-review [35,45,50] have demonstrated beneficial effects in community set-
tings, although follow-up duration was short (maximum of 8 weeks). Before implementation
in primary care, life-review and bibliotherapy need to be studied among primary care patients
with a longer follow-up duration. Furthermore, these studies had some issues regarding their
risk of bias, with a high risk of bias for the bibliotherapy studies [37,44,47,48] and a moderate
risk of bias for two of the life-review studies [35,45], and these concerns need to be addressed
in a future RCT conducted in primary care. Finally, the effect of behavioral activation therapy
seems promising in a pilot cohort study conducted in primary care [26], and is currently being
investigated in a well-designed RCT in primary care [59]. In addition to this latter RCT,
also PST, bibliotherapy, and life-review should be studied in a RCT in primary care among
depressed patients confirmed by a diagnostic interview and with at least a one-year follow-up.
Limitations
First, although we decided to review the results narratively, we did diverge from the published
protocol to perform a meta-analysis concerning the effect of CBT in primary care. This was
because most of the included studies in primary care focused on CBT and the combined results
of the individual studies were inconclusive. Although only two of the five individual studies
indicated a beneficial effect of CBT, the meta-analysis confirmed a small but beneficial effect.
Too few studies focusing on other non-pharmacological treatment options were conducted to
perform a meta-analysis for these interventions; for example, two studies focused on exercise
and both concluded that it was ineffective at follow-up, whereas only single studies were con-
ducted for the other treatment modalities. Since we aimed to present an overview of the evi-
dence for non-pharmacological treatments for late-life depression within primary care, we
decided not to perform meta-analyses of studies conducted in the community, but to narra-
tively review these studies in order to identify promising non-pharmacological treatments.
Second, one of the search terms was “general practice OR synonym,” so we only found a few
studies that were conducted in the community in the primary search. Although these settings
were not the focus of our review, we wanted to include all studies that focused on non-pharma-
cological treatment options in primary care. Due to careful selection of studies from previous
systematic reviews and meta-analyses, we could find and included more studies conducted in
a community (n = 15) setting, consistent with the aim of our review (Fig 1). However, we can-
not ignore the possibility that we did not include all studies focusing on non-pharmacological
interventions for late-life depression conducted in a community setting. Third, included stud-
ies differed in their depression inclusion criterion, which may have introduced heterogeneity
and thus may have affected the results of this review. However, the observed heterogeneity in
our meta-analysis was small (I2 = 0%). Finally, limitations of included studies should also be
acknowledged; such as the low number of included participants in primary care studies and
the short follow-up period in community studies.
Conclusion
Through this systematic review and meta-analysis, we aimed to provide general practitioners
with a comprehensive summary of the available evidence for non-pharmacological treatments
in late-life depression in primary care. We found a limited amount of studies studying a wide
variety of non-pharmacological interventions. Moreover, these studies differed in their defini-
tion of depression, definition of remission, and follow-up duration. Although this limits the
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evidence for specific interventions, it does give merit for several promising therapeutic options
for treatment of late-life depression within primary care. CBT was the only treatment option
meeting the highest level of evidence according to the GRADE (Grading of Recommendations
Assessment, Development and Evaluation) criteria, with a small but beneficial effect after
meta-analysis. However, a wealth of alternative options were identified that could be delivered
by well-trained nurses based on evidence that exists from studies in a community setting. This
review indicates that bibliotherapy, life-review, PST, and behavioral activation therapy are the
options most likely to be of benefit in primary care settings, but the paucity of high-quality
research means that we can only conclude that these options warrant further investigation in
RCTs performed in primary care.
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